Cobicistat (GS-9350)
Catalog No. A11277
Cobicistat (GS-9350)是有效,选择性的细胞色素酶P450 3A (CYP3A)抑制剂,包括重要的cyp3a4亚型。它还抑制肠道转运蛋白,增加几种hiv药物的整体吸收,包括atazanavir、darunavir和tenofovir alafenamide延胡索酸盐。
Catalog Num | A11277 |
---|---|
M. Wt | 766.0 |
Formula | C40H53N7O5S2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1004316-88-4 |
Synonyms | GS9350 |
SMILES | CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5 |
Cobicistat (GS-9350)是有效,选择性的细胞色素酶P450 3A (CYP3A)抑制剂,包括重要的cyp3a4亚型。它还抑制肠道转运蛋白,增加几种hiv药物的整体吸收,包括atazanavir、darunavir和tenofovir alafenamide延胡索酸盐。
Targets
CYP3A | ||||
30 nM-285 nM |
In vitro (25°C) | DMSO | 85 mg/mL (109.53 mM) | |
Water | Insoluble | ||
Ethanol | 85 mg/mL (109.53 mM) | ||
In vivo | 5% DMSO+40% PEG 300+ddH2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 13.05 mL | 65.27 mL | 130.55 mL |
0.5 mM | 2.61 mL | 13.05 mL | 26.11 mL |
1 mM | 1.31 mL | 6.53 mL | 13.05 mL |
5 mM | 0.26 mL | 1.31 mL | 2.61 mL |
*The above data is based on the productmolecular weight 766.0 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.